Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis.
Kanda T, Yasui S, Nakamura M, Nakamoto S, Takahashi K, Wu S, Sasaki R, Haga Y, Ogasawara S, Saito T, Kobayashi K, Kiyono S, Ooka Y, Suzuki E, Chiba T, Maruyama H, Imazeki F, Moriyama M, Kato N.
Kanda T, et al. Among authors: moriyama m.
Oncotarget. 2018 Feb 3;9(14):11631-11637. doi: 10.18632/oncotarget.24391. eCollection 2018 Feb 20.
Oncotarget. 2018.
PMID: 29545925
Free PMC article.